Novartis Gets Bricks And Mortar Money: Last Vaccine Support From Bush Administration
This article was originally published in The Pink Sheet Daily
Executive Summary
Commercial production at North Carolina facility supported by the HHS grant is at least three years away.
You may also be interested in...
Cell-Based Vaccine Development Gives Protein Sciences The Chills; Challenges Include Getting Advisory Committees To Accept FDA Decisions
Developing a new class of medical products takes creativity and perseverance by both sponsors and regulators, but as Protein Sciences' experience shows, bringing advisory committees up to speed on novel technologies can be just as important and challenging
Cell-Based Vaccine Development Gives Protein Sciences The Chills; Challenges Include Getting Advisory Committees To Accept FDA Decisions
Developing a new class of medical products takes creativity and perseverance by both sponsors and regulators, but as Protein Sciences' experience shows, bringing advisory committees up to speed on novel technologies can be just as important and challenging
Flu Vaccine Funds From Gov’t Could Help Firms Upgrade Production Facilities
Federal coffers could be tapped to pay for construction or rehabilitation of privately owned vaccine production facilities under a supplemental appropriations bill passed by the House May 14